Wellthy Therapeutics Demonstrates Sustained Improvements in Blood Glucose Control and Variability over 6 months

~Study presented at the American Diabetes Association's 80th Annual Sessions showed a sustained reduction of average blood glucose by 25 mg/dl and hypoglycemic events by 80% over 6 months~ Digital therapeutics innovator Wellthy…